Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease. (Q54373732)

28 May 2018

title

Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease. (English)

1 reference

28 May 2018

author

Asad Vaisi-Raygani

2

1 reference

28 May 2018

Zohreh Rahimi

7

1 reference

28 May 2018

Parvin Pasalar

6

object named as

Parvin Pasalar

1 reference

28 May 2018

author name string

Massoud Saedi

1

1 reference

28 May 2018

Shahnaz Khaghani

3

1 reference

28 May 2018

Ahmad Shariftabrizi

4

1 reference

28 May 2018

M Rezaie

5

1 reference

28 May 2018

Tayebeh Pourmotabbed

8

1 reference

28 May 2018

publication date

11 May 2011

1 reference

28 May 2018

Molecular Biology Reports

published in

1 reference

28 May 2018

volume

39

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

555-562

1 reference

28 May 2018

Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Toll-like receptors 4 induces expression of matrix metalloproteinase-9 in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

The emerging concept of vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Disruption of the myocardial extracellular matrix leads to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

21 January 2018

12 December 2020

Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1

2 references

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

21 January 2018

12 December 2020

Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0770-X

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

21 January 2018

1 reference

12 December 2020

Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study

1 reference

12 December 2020

Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran

1 reference

12 December 2020

Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury

1 reference

12 December 2020

The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria

1 reference

12 December 2020

Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in southern Iran

1 reference

12 December 2020

Plasma lipids and lipoproteins in children and young adults with major β-thalassemia from western Iran: influence of genotype

1 reference

12 December 2020

Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran

1 reference

12 December 2020

The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients

1 reference

12 December 2020

Butyrylcholinesterase K variant and the APOE-ε4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients

1 reference

12 December 2020

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

1 reference

12 December 2020

Quantitative zymography: detection of picogram quantities of gelatinases

1 reference

12 December 2020

Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention

1 reference

12 December 2020

10.1007/S11033-011-0770-X

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018